Jushi (OTCMKTS:JUSHF - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.06) EPS for the quarter, hitting analysts' consensus estimates of ($0.06), Zacks reports. The company had revenue of $65.05 million during the quarter, compared to the consensus estimate of $64.67 million.
Jushi Stock Performance
JUSHF stock traded up $0.04 during midday trading on Friday, reaching $0.68. 398,505 shares of the company's stock traded hands, compared to its average volume of 417,583. The company has a 50-day moving average price of $0.40 and a two-hundred day moving average price of $0.35. Jushi has a 52 week low of $0.22 and a 52 week high of $0.73. The firm has a market capitalization of $133.10 million, a PE ratio of -2.33 and a beta of -0.98.
About Jushi
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Further Reading

Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.